http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-367114-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3826
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-38
filingDate 1969-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1971-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-367114-A1
titleOfInvention A METHOD FOR THE PREPARATION OF PROPE-NILPHOSPHONIC ACID COMPOUNDS.
abstract A cis-olefinic compound of the formula CH 3 CH=CHP(O)(OR) 2 wherein R is H, a univalent substituted or unsubstituted hydrocarbon radical or an equivalent of a cation which may be a metal, NH 4 or amine cation, the two R's being the same or different, is obtained by treating a compound of the formula wherein X is halogen, Y is halogen or OH or an acyloxy, sulphonyloxy or nitrosyl group and R is as defined above with an appropriate reagent selected from a reducing metal (e.g. zinc), a reducing metal salt (e.g. chromous chloride or stannous chloride), sodium sulphite, sodium iodide, diphenyl telluride, a triaryl phosphine, a trialkyl phosphine and a trialkyl phosphite. The halohydrin compound in which Y is OH may be obtained by reacting the (+) isomer of the cis-epoxide of the formula with a hydrogen halide which is preferably bubbled into a solution or suspension of the epoxy compound in an inert organic solvent and the halohydrin product may be directly converted to the olefinic compound by treatment with a reducing metal or reducing metal salt, if desired in the presence of a tertiary amine and POCl 3 , the conversion being generally effected in an inert organic solvent. In an alternative procedure the halohydrin is halogenated to form the corresponding dihalide, i.e. compounds in which Y is a halogen atom, the halogenation being suitably effected with a concentrated halogen acid, a phosphorus halide or oxyhalide, e.g. PBr 3 or POCl 3 or with a thionyl halide, e.g. thionyl chloride. Dehalogenation may suitably be effected by treatment with Zn, chromous-, titanous-, vanadous-, stannous-, or ferrouschloride, sodium sulphite, sodium iodide, diphenyl telluride, a triaryl or trialkyl phosphine or a trialkyl phosphite. The halohydrin may also be acylated with an acid chloride or anhydride, sulphonylated, e.g. with methane-, ptoluene-sulphonyl- or p-bromobenzene-sulphonyl chloride, or nitrosated, e.g. with nitrosyl chloride, to form the corresponding compounds in which Y is acyloxy, sulphonyloxy or nitrosyl which are then treated with a reducing metal or reducing metal salt to form the cis-propenyl phosphonic acid compound. The (+) isomer of (cis-1,2-epoxy-propyl)- phosphonic acid may be obtained by resolving a racemic mixture obtained by selectively reducing an ester of propynylphosphonic acid to the corresponding ester of cis-propenylphosphonic acid, hydrolysing the ester to the corresponding free acid and then epoxidizing the free acid to the ( ) epoxy acid and a detailed example is given for such stepwise process for the production of (+ )(cis-1,2-epoxypropyl)phosphonic acid which is recovered in the form of its diammonium salt. The latter may be converted to the sodium salt which on treatment with silver nitrate yields the silver salt which on reaction with an alkyl, alkenyl, alkynyl or aralkyl halide gives the corresponding esters of ( + ) (cis-1,2-epoxypropyl)phosphonic acid. The aryl esters may be obtained by dissolving propenyl phosphonic acid, thionyl chloride and pyridine in benzene, reacting the acid chloride formed with phenol or a substituted phenol and then epoxidizing the product.
priorityDate 1968-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407330845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410510985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12521972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457773519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23661981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455728551
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452754495
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448906802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451859813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408795568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559537
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70995
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474448
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66355
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10290777
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546718
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7396
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415748511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6436667
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID996
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448924711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421123178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449013851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107908
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458437694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414861851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17601
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454702160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426598418

Total number of triples: 64.